Here is the thing about a partner who wants out of a building that is 99 percent leased.
It is almost never about the building.
China Life Insurance Group — one of China’s largest state-owned insurers — has put its minority stake in 1285 Sixth Avenue up for sale, The Real Deal reported Wednesday. The asking price implies a $1.4 billion valuation for the 42-story, 1.8 million-square-foot tower. RXR, its partner since 2016, is keeping its majority position.
If you underwrite Manhattan office, allocate capital to it, or simply need to know what a real bid looks like right now, this trade is worth more of your attention than the headline number suggests. In the next few minutes you’ll get the basis math that actually matters, the reason the timing is deliberate rather than distressed, the one lease that governs the upside, and the honest read on what a clearing price here would tell the rest of the market.
The Basis Math Nobody Puts in the Press Release
Run the two numbers side by side. That is the whole story.
- 2016 purchase: RXR and China Life bought 1285 Sixth for $1.65 billion — roughly $917 per square foot.
- 2026 ask: a $1.4 billion valuation — roughly $778 per square foot.
That is about 15 percent below the 2016 basis, in nominal dollars, ten years later. Adjust for a decade of inflation and the real erosion is considerably steeper.
Now hold that against the operating reality: the building is 99 percent occupied. Its rent roll includes UBS, ad agency BBDO, and Big Law firm Ropes & Gray. The offering memo cites more than $2 billion of contractual rent and describes the cash flow as “durable.” Latham & Watkins expanded here in March. The asset hit 100 percent occupancy last year.
So this is not a broken building being dumped. This is a fully leased trophy on the Sixth Avenue corridor pricing below where it traded a decade ago. That spread — full occupancy, discounted basis — is the single most useful data point in the story. It tells you the repricing of Manhattan office was never really about vacancy. It was about the cost of money.
Why 2016 Was the Peak, and Why That Matters Now
The 2016 purchase sat at the crest of a specific wave: Chinese capital pouring into New York commercial real estate. Anbang, HNA, China Life, Ping An — for a stretch, mainland insurers and conglomerates were the most aggressive bidders in the market, and they were not underwriting to New York cap rates. They were underwriting to a capital-flight thesis and a currency view.
Beijing closed that window. Capital controls tightened, regulators forced deleveraging, and the outbound buyers turned into forced or semi-forced sellers. Anbang’s exit from the Waldorf and its Strategic Hotels portfolio wrote the template.
China Life’s move is the same story arriving on a slower clock. The partner isn’t selling because 1285 Sixth stopped working. It is selling because a state-owned Chinese insurer holding a passive minority position in a Manhattan office tower is a legacy allocation from a policy era that no longer exists.
Read the seller before you read the asset. A motivated non-operating partner produces a very different price than a control sale of the same building would.
The 2023 Loan Modification Is the Real Backstory
You cannot price this stake without the debt.
In October 2023, RXR and China Life negotiated a loan modification with Morgan Stanley and AIG. The terms:
- The partners injected $220 million of fresh equity.
- That equity paid down the balance and built reserves against a roughly $980 million mortgage.
- The interest rate went up.
- The maturity was extended by five years.
RXR president Michael Maturo was candid about what that deal was for at the time:
“Everyone’s very confident in this building. It’s got very strong cash flow, and this was very helpful in getting [the lenders] feeling good about doing an extension and modification on the loan. I think everyone was very satisfied in terms of where we’re winding up at the end of the day and giving this building some time to get through this liquidity period. After the five-year term, hopefully we’ll be in a better environment to refinance.”
Two things follow from that quote. First, the extension bought runway to roughly 2028 — the sale is happening comfortably inside the window, not against a wall. Second, China Life already wrote a check in 2023 to keep this position alive. Any institution that funds a defensive recapitalization and then markets its stake three years later has made a portfolio decision, not a property decision.
The Lease That Governs the Upside
The offering memo points to one specific source of future income growth: UBS’s lease comes up for renewal in 2032.
That is the pitch, and it is a real one. A below-market anchor lease rolling six years out, in a 99-percent-leased tower on a corridor with tightening supply, is exactly the kind of embedded mark-to-market that institutional buyers will pay for.
It is also the pitch’s weakness. Six years is a long duration to underwrite as your upside case. A buyer of a minority interest is being asked to accept passive economics today for a re-leasing event two capital cycles away — with no control over how RXR negotiates it. The gap between what that optionality is worth to RXR and what it is worth to a passive LP is precisely where this deal will get priced.
RXR has already demonstrated it can execute on that front. In November 2024 it signed Ropes & Gray to a 430,000-square-foot lease — one of Manhattan’s largest deals that year. The operator is not the question here. The structure is.
The Market Backdrop Is Genuinely Strong
Timing is the most defensible part of this decision.
Manhattan office leasing hit nearly 24 million square feet in the first half of 2026, according to Colliers — putting the market on pace for its most active year since 2000.
Sit with that. Not the best year since the pandemic. Since 2000. The recovery narrative in Manhattan office stopped being a narrative some time ago; the leasing volume is now simply a fact. Vacancy is being absorbed, concessions are compressing in the quality tiers, and the flight-to-quality trade has resolved in favor of exactly the kind of asset 1285 Sixth is.
A Newmark team led by Adam Spies, Marcella Fasulo, and Josh King is marketing the stake — the group you hire when you want a deep institutional process rather than a quiet off-market clearing.
What Operators Should Actually Take From This
Three takeaways, ranked by how much they should change your behavior:
- Price discovery on partial interests is back. Minority-stake sales in trophy assets had largely stopped clearing. That one is being openly marketed by a top-tier team signals the bid side has real depth again.
- A discount to 2016 basis on a 99-percent-leased tower is the market’s honest verdict on rates, not on offices. Stop conflating the two when you underwrite.
- Watch where this clears, not where it’s asked. If $1.4 billion holds, it resets the comp for every large Sixth Avenue and Rockefeller-adjacent asset. If it trades meaningfully below, the flight-to-quality premium is thinner than the leasing numbers imply.
The building was never the risk. The capital stack and the cap rate were. That is the lesson worth carrying into your next underwriting.
Where do you land — is $778 per foot for a 99-percent-leased Sixth Avenue tower a bargain or an accurate mark? I’d genuinely like to hear from people pricing this product right now. Drop your read below.
